pentosidine has been researched along with Cardiac Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hartog, JW; Hillege, HL; Jaarsma, T; Roze, JF; Schalkwijk, C; van der Horst, IC; van der Meer, P; van Veldhuisen, DJ; Voors, AA; Willemsen, S | 1 |
| Arimoto, T; Hirono, O; Koyama, Y; Kubota, I; Niizeki, T; Nitobe, J; Nozaki, N; Shishido, T; Takahashi, H; Takeishi, Y; Tsunoda, Y; Watanabe, T | 1 |
2 other study(ies) available for pentosidine and Cardiac Failure
| Article | Year |
|---|---|
The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Female; Glycation End Products, Advanced; Heart Failure; Humans; Kaplan-Meier Estimate; Lysine; Male; Mass Spectrometry; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Severity of Illness Index; Stroke Volume | 2012 |
High serum level of pentosidine, an advanced glycation end product (AGE), is a risk factor of patients with heart failure.
Topics: Aged; Arginine; Biomarkers; Cardiotonic Agents; Case-Control Studies; Comorbidity; Diabetes Complications; Digoxin; Diuretics; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Japan; Lysine; Male; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Prospective Studies; Renal Insufficiency; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Survival Analysis | 2007 |